CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
of Best Available Therapy (BAT) for treatment-resistant relapsing multiple sclerosis (MS). Participants will be randomized...
Phase 3
Seattle, Washington, United States and 21 other locations
due to cancer or other illnesses such as Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), Parkinson'...
Phase 2
Seattle, Washington, United States and 24 other locations
This study will evaluate if relapsing-remitting MS patients that have not had a relapse in the past year would benefit from a switch to ofat...
Phase 4
Seattle, Washington, United States and 42 other locations
clinical study of AZD0120, a BCMA/CD19 dual targeting CAR+ T-cell therapy, to evaluate the safety and tolerability in adult participants with Multiple...
Phase 1
Seattle, Washington, United States and 12 other locations
The MS pilot study will assess the safety and investigate the remyelinating effects of the SetPoint System (study device) in adult patients ...
Seattle, Washington, United States and 2 other locations
To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)...
Phase 3
Seattle, Washington, United States and 228 other locations
) neo-antigen in subjects with relapsing multiple sclerosis (RMS).COVID-19 sub-study:The purpose of this research sub-study is to e...
Phase 3
Kirkland, Washington, United States and 298 other locations
Clinical trials
Research sites
Resources
Legal